Evidence map›Paper›PMID 24730679›Full record

ReviewAntioxidants & redox signaling2015

The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.

Mark R Hellmich, Ciro Coletta, Celia Chao, Csaba Szabo

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 235 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Targeting macro- and micro-nutrient regulation of HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Review
  7. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  8. Article
  9. Dencichine attenuates the virulence of Fusobacterium nucleatum by targeting hydrogen sulfide-producing enzyme.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  10. Review
  11. Synthesis, HScientific reports · 2025
    Article
  12. Review
  13. Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.Redox report : communications in free radical research · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mark R Hellmich1 Department of Surgery, University of Texas Medical Branch , Galveston, Texas.
Ciro Coletta
Celia Chao
Csaba Szabo
The University of Texas Medical Branch at Galveston · US

Funding

UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Role of Hydrogen Sulfide in Colorectal TumorsR01CA175803 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HELLMICH, MARK R, SZABO, CSABA · 2014 to 2018
$1.5M
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal CancerK08CA125209 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHAO, CELIA · 2009 to 2013
$643k
NCATS NIH HHS 8UL1TR000071NCI NIH HHS K08CA125209NCI NIH HHS R01CA175803
6 · The paper itself

Abstract

significanceCancer represents a major socioeconomic problem; there is a significant need for novel therapeutic approaches targeting tumor-specific pathways. RECENT ADVANCES: In colorectal and ovarian cancers, an increase in the intratumor production of hydrogen sulfide (H2S) from cystathionine β-synthase (CBS) plays an important role in promoting the cellular bioenergetics, proliferation, and migration of cancer cells. It also stimulates peritumor angiogenesis inhibition or genetic silencing of CBS exerts antitumor effects both in vitro and in vivo, and potentiates the antitumor efficacy of anticancer therapeutics. CRITICAL ISSUES: Recently published studies are reviewed, implicating CBS overexpression and H2S overproduction in tumor cells as a tumor-growth promoting "bioenergetic fuel" and "survival factor," followed by an overview of the experimental evidence demonstrating the anticancer effect of CBS inhibition. Next, the current state of the art of pharmacological CBS inhibitors is reviewed, with special reference to the complex pharmacological actions of aminooxyacetic acid. Finally, new experimental evidence is presented to reconcile a controversy in the literature regarding the effects of H2S donor on cancer cell proliferation and survival. FUTURE DIRECTIONS: From a basic science standpoint, future directions in the field include the delineation of the molecular mechanism of CBS up-regulation of cancer cells and the delineation of the interactions of H2S with other intracellular pathways of cancer cell metabolism and proliferation. From the translational science standpoint, future directions include the translation of the recently emerging roles of H2S in cancer into human diagnostic and therapeutic approaches.

Indexed as

Aminooxyacetic AcidAnimalsAntineoplastic AgentsCell ProliferationColorectal NeoplasmsCystathionine beta-SynthaseEnergy MetabolismFemaleHumansHydrogen SulfideOvarian NeoplasmsAminooxyacetic AcidAntineoplastic AgentsCystathionine beta-SynthaseHydrogen Sulfide

Identifiers

PMID24730679
PMCPMC4307161
OpenAlexW1973017725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.